title: Graft survival and its determinants: a 3 year national experience with liver transplantation in Israel.
abstract: BACKGROUND
  There is a dearth of organs for liver transplantation in Israel. Enhancing our understanding of factors affecting graft survival in this country could help optimize the results of the transplant operation.
  
  
  OBJECTIVE
  To report 3 years national experience with orthotopic liver transplantation, and to evaluate patient and perioperative risk factors that could affect 1 year graft survival.
  
  
  METHODS
  The study related to all 124 isolated adult liver transplantations performed in Israel between October 1997 and October 2000. Data were abstracted from the medical records. One-year graft survival was described using the Kaplan-Meier survival curve and three multivariate logistic regression models were performed: one with preoperative case-mix factors alone, and the other two with the addition of donor and operative factors respectively.
  
  
  RESULTS
  Of the 124 liver transplantations performed, 32 failed (25.8%). The 1 year survival was lower than rates reported from both the United States and Europe but the difference was not significant. Of the preoperative risk factors, recipient age > 60 years, critical condition prior to surgery, high serum bilirubin and serum hemoglobin < or = 10 g/dl were independently associated with graft failure, adjusting for all the other factors that entered the logistic regression equation. Extending the model to include donor and operative factors raised the C-statistic from 0.79 to 0.87. Donor age > or = 40, cold ischemic time > 10 hours and a prolonged operation (> 10 hours) were the additional predictors for graft survival. A MELD score of over 18 was associated with a sixfold increased risk for graft failure (odds ratio = 6.5, P = 0.001).
  
  
  CONCLUSIONS
  Graft survival in Israel is slightly lower than that reported from the U.S. and Europe. Adding donor and operative factors to recipient characteristics significantly increased our understanding of 1 year survival of liver grafts.
authors.affiliation: Department of Health Services Research, Ministry of Health, Jerusalem, Israel. anat.zohar@moh.health.gov.il
authors.forename: Anat
authors.initials: A
authors.lastname: Ekka-Zohar
authors.forename: Yana
authors.initials: Y
authors.lastname: Zitser-Gurevich
authors.forename: Micha
authors.initials: M
authors.lastname: Mandel
authors.forename: Inbal
authors.initials: I
authors.lastname: Weiss-Salz
authors.forename: Sharon
authors.initials: S
authors.lastname: Nir
authors.forename: Eitan
authors.initials: E
authors.lastname: Mor
authors.forename: Nakash
authors.initials: N
authors.lastname: Richard
authors.forename: Hadar
authors.initials: H
authors.lastname: Merhav
authors.forename: Rafael
authors.initials: R
authors.lastname: Bruck
authors.forename: Elisheva
authors.initials: E
authors.lastname: Simchen
mesh_terms: D000328:Adult; D000368:Aged; D003953:Diagnosis-Related Groups; D005260:Female; D006085:Graft Survival; D006801:Humans; D007557:Israel / Q000453:epidemiology; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D016015:Logistic Models; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D016019:Survival Analysis